Compare conditions

Put any two — or three — conditions side by side, adult or pediatric, to spot the look-alike differences fast, row by row.

BPH LUTS

—

In one line

·Benign prostatic hyperplasia (BPH) (non-cancerous growth of the prostate gland) squeezes the urethra (the tube that drains urine from the bladder), causing weak stream, frequent trips to the bathroom, sudden urges, nighttime wake-ups to urinate, and a bladder that never feels fully empty.

—

Normal physiology

·The prostate gland wraps around the urethra just below the bladder neck like a doughnut around a straw. The detrusor muscle (the thick wall of the bladder) squeezes to push urine out, while the internal urethral sphincter (a ring of muscle at the bladder outlet) relaxes to let urine pass. When everything works together, the bladder empties completely at low pressure, urine flows in a smooth strong stream, and you walk away feeling empty and comfortable. Keep this normal picture in your mind, because every symptom of BPH is a breakdown of that smooth, low-pressure flow.

—

What goes wrong

·One upstream problem—prostate tissue growing inward and squeezing the urethra—explains every urinary symptom in BPH. It is a mechanical blockage, not a mystery.

—

Hallmark signs

·Weak urinary stream
·Hesitancy (delay in starting urination)
·Intermittent stream (stopping and starting during urination)
·Urinary frequency (urinating more than 8 times a day)
·Waking at night to urinate (Nocturia) (waking 2 or more times at night to urinate)
·Urgency (sudden, strong need to urinate right away)
·Post-void dribbling (urine leaks after you finish urinating)
·Sensation of incomplete bladder emptying

—

Red flags · escalate now

·Acute urinary retention (sudden inability to pass any urine, severe lower belly pain, and a swollen bladder you can feel) – needs emergency catheter to drain the bladder and prevent kidney damage or bladder rupture.
·Visible blood in the urine (gross blood in the urine (hematuria)) – can signal bladder cancer, bladder stones, or bleeding prostate tissue; requires camera exam of the bladder (cystoscopy) and imaging to rule out cancer.
·Recurrent urinary tract infections (two or more in six months) – means urine is sitting in the bladder too long, letting bacteria grow; raises concern for stones or kidney damage from backup.
·Rising creatinine or swollen kidneys on ultrasound (hydronephrosis) – shows urine is backing up into the kidneys, which can cause permanent kidney damage if not relieved quickly.
·Symptoms not improving with maximum medicine – may mean severe blockage, a bladder muscle that's too weak to push, bladder stones, scar narrowing of the urethra (stricture), or bladder cancer; needs pressure-flow testing (urodynamics) and cystoscopy.

—

Workup

·Urinalysis (UA)
·Serum creatinine and estimated glomerular filtration rate (eGFR)
·Prostate-specific antigen (PSA) after shared decision-making
·Post-void residual (PVR) volume by bladder ultrasound or catheterization
·Renal and bladder ultrasound (if creatinine elevated or high PVR)
·Uroflowmetry (optional, often done in urology clinic)

—

Treatment

·Lifestyle modification: reduce caffeine and alcohol, limit evening fluids, practice timed voiding (scheduled bathroom trips every 2–3 hours)
·Alpha-blocker: tamsulosin 0.4 mg daily or alfuzosin 10 mg daily
·5-alpha reductase inhibitor: finasteride 5 mg daily or dutasteride 0.5 mg daily
·Combination therapy: alpha-blocker (tamsulosin) plus 5-alpha reductase inhibitor (finasteride or dutasteride) for moderate-to-severe LUTS or prostate volume above 40 mL
·Minimally invasive or surgical intervention: TURP (transurethral resection of prostate), HoLEP (holmium laser enucleation), UroLift, or Rezūm (water vapor thermal therapy) for severe symptoms, medication failure, recurrent retention, kidney injury, or bladder stones
·Tadalafil 5 mg daily for LUTS not controlled by alpha-blocker alone, or when erectile dysfunction coexists
·Anticholinergic (oxybutynin, tolterodine) or beta-3 agonist (mirabegron) for persistent urgency and frequency after alpha-blocker, only if post-void residual is low and no retention risk

—

NCLEX trap

·In BPH (benign prostatic hyperplasia, noncancerous prostate enlargement) with LUTS (lower urinary tract symptoms), if the bladder cannot empty completely, anticholinergic drugs weaken bladder contraction and worsen urinary retention (inability to empty the bladder), causing urine to back up to the kidneys. Always measure post-void residual first. The correct treatment is to relieve the urethral obstruction (blockage of the urine tube), not suppress bladder activity.
·Urinary tract infection can occur secondary to BPH LUTS because stagnant urine (urine that sits in the bladder) creates a breeding ground for bacteria. Antibiotics treat the infection, but they do not relieve prostatic obstruction (blockage caused by enlarged prostate). Treat both: antibiotics for infection and prostate-directed therapy (alpha-blocker or 5-alpha reductase inhibitor) for the obstruction.
·In BPH LUTS, waking at night to urinate (nocturia) occurs because prostatic obstruction prevents complete bladder emptying during the day, leaving the bladder chronically full. At night, the body attempts to eliminate the retained volume. Limiting evening fluid intake helps modestly, but the primary problem is prostatic obstruction, not fluid intake.
·BPH LUTS severity is determined by symptom impact on quality of life and objective findings, not post-void residual alone. If the patient has decreased urinary stream (weak flow) and bothersome symptoms, treatment is indicated even with low residual volume. Assess symptom severity using validated tools like the International Prostate Symptom Score (IPSS), not just residual volume.
·Begin with conservative measures (timed voiding, caffeine reduction, avoiding evening fluids). Then initiate monotherapy with an alpha-blocker for moderate symptoms. Add a 5-alpha reductase inhibitor only if the alpha-blocker provides insufficient relief or if prostate volume exceeds 40 grams on exam or imaging. Sequential therapy allows assessment of each intervention's efficacy and minimizes polypharmacy (use of multiple medications).

—

Install Maldek by Hill as an app — studies work even offline